Sonoma Pharmaceuticals (SNOA) Operating Expenses (2010 - 2026)

Sonoma Pharmaceuticals has reported Operating Expenses for 17 years, with the latest figure at $2.6 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 2.27% year-over-year to $2.6 million in Q2 2026; TTM through Jun 2026 was $9.9 million, a 7.34% increase from a year earlier, with the FY2026 full-year figure at $9.9 million, up 7.64% from the prior year.
• Operating Expenses was $2.6 million for Q2 2026 at Sonoma Pharmaceuticals, up from $2.5 million in the prior quarter.
• The five-year high for Operating Expenses was $3.2 million in Q1 2022, with the low at $2.0 million in Q1 2023.
• Average Operating Expenses over 5 years is $2.4 million, with a median of $2.5 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 36.28% in 2023, then grew 24.32% in 2024.
• Over 5 years, Operating Expenses stood at $2.7 million in 2022, then retreated by 13.55% to $2.3 million in 2023, then fell by 0.13% to $2.3 million in 2024, then rose by 1.17% to $2.3 million in 2025, then advanced by 12.41% to $2.6 million in 2026.
• The last three Operating Expenses figures came in at $2.6 million (Q2 2026), $2.5 million (Q1 2026), and $2.3 million (Q4 2025), per Business Quant data.